Abstract:The Hedgehog signaling pathway is a key regulator of embryonic development, cell proliferation, differentiation, stemness, and tissue homeostasis, and its aberrant activation has been implicated in the development and progression of multiple ocular tumors. This review summarizes the molecular alterations, biological functions, and therapeutic relevance of Hedgehog signaling in eyelid and periocular basal cell carcinoma, sebaceous carcinoma, retinoblastoma, and ocular melanoma. Overall, the biological and clinical significance of Hedgehog signaling varies across ocular tumor types. Further studies integrating multi-omics analyses, functional validation, predictive biomarkers, and prospective clinical investigation are needed to clarify pathway dependence, mechanisms of resistance, and the therapeutic value of Hedgehog pathway targeting in ocular tumors.